Summary & Overview
CPT 0891T: Accelerated fMRI‑guided Theta‑Burst Stimulation, Subsequent Day
CPT code 0891T denotes a subsequent treatment day for accelerated, repetitive high‑dose functional connectivity MRI–guided theta‑burst stimulation (a noninvasive brain stimulation therapy). This code captures the provider’s use of neuronavigation to target treatment, the delivery of the theta‑burst protocol, and direct patient management on treatment days after initiation. Nationally, the code matters as novel neuromodulation therapies expand and payers refine coverage and coding guidance for MRI‑guided, high‑dose protocols.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication highlights how these payers approach coverage, code recognition, and reimbursement for advanced neuromodulation services.
Readers will learn concise benchmarks and interpretation for CPT code 0891T, clinical context around accelerated theta‑burst protocols, typical sites of service, and where to find policy updates relevant to this emerging treatment. The summary provides a national perspective on coding placement and operational considerations for providers and billing teams. Data not available in the input is noted where specific payer rates, associated taxonomies, and ICD‑10 mappings would normally appear.
Billing Code Overview
CPT code 0891T describes a subsequent treatment day for an accelerated, repetitive high–dose functional connectivity MRI–guided theta–burst stimulation procedure. The provider employs neuronavigation to target brain regions, delivers the noninvasive brain stimulation treatment, and manages the patient during that subsequent treatment session.
Service type: Therapeutic noninvasive brain stimulation (theta-burst stimulation), subsequent treatment day
Typical site of service: Outpatient specialty clinic or ambulatory neuromodulation center
Clinical & Coding Specifications
Clinical Context
A typical patient is a 32–65 year-old adult with treatment-resistant major depressive disorder who returns for a subsequent accelerated, repetitive high-dose functional connectivity MRI–guided theta-burst stimulation (TBS) session. The patient was evaluated in a neurostimulation clinic, cleared for repeated noninvasive brain stimulation, and scheduled for daily accelerated sessions over multiple days. On the day of service the provider performs neuronavigation using prior fMRI connectivity targets, delivers the TBS treatment, monitors acute tolerability, and documents clinical response and any adverse events. The clinical workflow includes pre-session brief assessment (mood, suicidality screen, headache/neurologic symptoms), positioning in the neuronavigation system, verification of treatment target via prior imaging or neuronavigation fiducials, delivery of the high-dose theta-burst stimulation protocol, immediate post-treatment observation, and documentation of the session as a subsequent treatment day using 0891T. Typical site of service is an outpatient neurostimulation clinic or ambulatory surgery center where the noninvasive device and neuronavigation equipment are available.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
52 | Reduced services | Use when the TBS session is partially performed or the device delivers a reduced treatment dose compared with the planned protocol. |